Blood pressure targets during surgery and thinking ability in cancer patients
Compares two blood pressure strategies during cancer surgery in people at high stroke risk.
Key facts
- Who runs it
- Zhejiang Cancer Hospital
- Where
- Hangzhou, ChinaSee the site
- Trial code
- Registry title
- Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients(PRECISION)
- Status
- Recruiting
- People taking part
- 214 people, planned
- Started
- 18 Sept 2024
- Planned end
- 1 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Norepinephrine or phenylephrine
- Record updated
- 2 December 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40 to 85 at high risk of stroke who are planning surgery for an abdominal tumor under general anesthesia. It compares two ways of managing blood pressure during surgery.
- Age
- 40 to 85 years
- Sex
- All sexes can join.
- Disease stage
- Planned surgery for an abdominal tumor (gynecological, urinary, hepatobiliary or gastrointestinal), expected to last more than 2 hours, under general anesthesia. High stroke risk: 3 or more risk factors on the stroke risk screening table. ASA class II or III.
- Earlier treatment
- Invasive arterial blood pressure monitoring before surgery. New stroke less than 3 months ago is not allowed.
Main reasons for not taking part
- Severe heart disease or severe liver function impairment (Child-Pugh class C)
- Needs kidney replacement therapy
- New stroke less than 3 months ago
- Emergency surgery
- History of mental illness, epilepsy, Parkinson's disease or myasthenia gravis
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients with high-risk stroke (combined with 3 risk factors or more according to the stroke risk screening table)
- Patients who plan to undergo surgery for abdominal tumors (gynecological, urinary, hepatobiliary, and gastrointestinal tumors) under general anesthesia are expected to have surgery duration >2 hours
- The ASA is rated as Class II or III
- Patients who underwent invasive arterial blood pressure monitoring before surgery signed informed consent
Who cannot take part
- Emergency surgery
- Situations where strict blood pressure management is not appropriate, such as controlled hypotension during surgery
- Patients with severe heart disease (severe valvular disease, sick sinus syndrome, high atrioventricular block without pacemaker implantation), grade III or above Liver function impairment (Child-Pugh class C)
- Need kidney replacement therapy; New stroke <3 months
- Preoperative history of mental illness, epilepsy, Parkinson's disease, or myasthenia gravis
- Speech, vision, or hearing impairment that prevents completion of a cognitive function assessment
- Patients do not want to participate in the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 85 years old?
Where in China
- Zhejiang Cancer HospitalHangzhou, ChinaContact: Yejing Zhu, PHDTaking people
About the trial
What the trial wants to find out
This is a randomized controlled study to explore whether perioperative blood pressure management with different strategies can reduce the incidence of delirium and postoperative cognitive impairment and serious perfusion related complications (persistent hypotension, new heart arrhythmia, cardiac insufficiency, new stroke, sudden death, etc.) within 30 days after stroke in cancer patients at high risk for stroke.
Read full original descriptionShow less
Patients were randomly divided into: 1) strict blood pressure management group: norepinephrine or phenylephrine maintenance intraoperative MAP≥85 mmHg, and 2) conventional blood pressure management group: intraoperative routine blood pressure management (MAP≥65mmHg).
The study included 424 subjects and was randomized to provide 90% efficacy. Secondary markers were unscrupulous cerebrovascular events (persistent hypotension, arrhythmia, cardiac insufficiency, new stroke, sudden death) within 30 days after surgery.
The 2 groups in the trial
- Strict Blood Pressure Management Group (MAP > 80 mmHg)Treatment being tested
Management strategy: For patients assigned to strict blood pressure management, stop taking ACEI (angiotensin converting enzyme inhibitors) or ARB (angiotensin receptor blockers) on the day of surgery. Other antihypertensive drugs can be given selectively depending on the patient's blood pressure level. Intraoperative use of norepinephrine or phenylephrine (norepinephrine 0.01-0.1μg/kg/min or phenylephrine 0.15-1.1 ug/kg/min). The actual infusion speed depends on achieving the target MAP.
Treatment: Norepinephrine or phenylephrine
- Management strategy of the conventional blood pressure management group (MAP>65mmHgNo study treatment, for comparison
For patients assigned to the conventional blood pressure management group, ACEI, ARB or calcium antagonists can be used until the morning of the day of surgery if the anesthesiologist deems it necessary. Intraoperative blood pressure management is based on routine, and it is not necessary to use pressor drugs prophylactically, which can be used according to the actual clinical situation. In general, intraoperative MAP should not be lower than 65mmHg. If there is no contraindication of hypotension, oral antihypertensive drugs can be resumed as soon as possible after surgery.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Different Intraoperative Blood Pressure Management Strategies on Postoperative Cognitive Function and Adverse Outcomes in Tumor Patients With High Risk Factors for Stroke
- Plain-language title
- Blood pressure targets during surgery and thinking ability in cancer patientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06711432, who can take part
- Record updated
- 2 December 2024